![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](cf6365contents.gif)
Acta Cryst. (2004). E60, o1463-o1464 [ doi:10.1107/S1600536804018665 ]
Abstract: The title compound [systematic name: (1R,2R,3S,6S,7S,7aR)-3-hydroxymethyl-1,2,6,7-tetrahydroxypyrrolizidine monohydrate or (2S,3R,4R,5R,6S,7S)-2-hydroxymethyl-1-azabicyclo[3.3.0]octan-3,4,6,7-tetraol monohydrate], C8H15NO5·H2O, was formed in a synthetic sequence in which there were several ambiguities in the stereochemistry of the reactions. Its crystal structure was determined to resolve these ambiguities.
Online 7 August 2004
Copyright © International Union of Crystallography
IUCr Webmaster